Yahoo Web Search

  1. Ad

    related to: gsk vaccines
  2. HCPs: Learn About AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted). Are You Ready To Make A Stocking Decision? View The Purchasing Options For AREXVY.

Search results

  1. us.gsk.com › en-us › companyVaccines | GSK US

    We deliver over two million vaccine doses per day to people living in over 160 countries. The vaccines in our portfolio have been helping to protect people from serious disease for well over 100 years, with our Marietta, PA site dedicated to smallpox vaccine production since 1882.

  2. GSK offers a broad range of vaccines for your appropriate pediatric and adult patients. Find more educational resources to support you in your practice.

  3. us.gsk.com › en-us › productsProducts | GSK US

    We deliver over 1.5 million doses of our vaccines every day; and 4 out of 10 infants born each year receive at least one GSK vaccine. Our vaccines portfolio targets infectious diseases at every stage of life, helping to protect people from RSV, meningitis, shingles, flu, polio and many more.

    Trademark
    Generic
    Product Area
    Advair Diskus
    salmeterol, fluticasone propionate
    General medicines
    Advair HFA
    salmeterol, fluticasone propionate
    General medicines
    Anoro Ellipta
    umeclidinium and vilanterol
    General medicines
    Arexvy
    respiratory syncytial virus vaccine, ...
    Vaccines
  4. www.gsk.com › en-gb › productsProducts | GSK

    We deliver over 1.5 million doses of our vaccines every day; and 4 out of 10 infants born each year receive at least one GSK vaccine. Our vaccines portfolio targets infectious diseases at every stage of life, helping to protect people from RSV, meningitis, shingles, flu, polio and many more.

  5. May 3, 2023 · US FDA approves GSKs AREXVY, the world’s first respiratory syncytial virus (RSV) vaccine for older adults. Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time.

  6. May 17, 2021 · GSK is collaborating with several organisations on COVID-19 vaccines by providing access to our adjuvant technology. In addition to our work with Sanofi, our collaboration with Medicago on an adjuvanted, plant-derived vaccine candidate is now in late-stage clinical trials.

  7. Feb 6, 2024 · The FDA has approved GSKs RSV vaccine for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. The use of this vaccine should be in accordance with official recommendations.

  1. Ad

    related to: gsk vaccines
  1. People also search for